MEDICAREPLUS INTERNATIONAL LTD

• ◆

  2 PSCs ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +9.1%

  £18,137,176 → £19,792,511

• Cash

  -73.9%

  £6,754,468 → £1,760,626

• Net assets

  -34.9%

  £9,719,302 → £6,323,214

• Employees

  +23.8%

  42 → 52

• Operating profit

  -8%

  £5,957,560 → £5,479,748

• Profit before tax

  -5.8%

  £6,144,024 → £5,786,635

• Wages

  +16.4%

  £2,102,638 → £2,448,370

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have prepared cash flow forecasts for a period to 31 March 2027 which indicate that, taking account of reasonably possible downsides, including trading continuing at levels experienced during the year ended 31 March 2025, the company will have sufficient funds to meet its liabilities as they fall due for that period. Consequently, the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”

Group structure

1. MEDICAREPLUS INTERNATIONAL LTD · parent
   1. Medicareplus Limited 100% · England & Wales · Dormant

Significant events

• “During the year the Company incurred exceptional costs of £830,503 in respect of Group restructuring and exploring future strategic plans.”
• “The Company has been actively promoting existing lines as well as investing in the development of new product lines and is continuing to bring these to market. The directors are optimistic that the Company will achieve continued revenue growth in 2025/26.”
• “In June 2025 the company has been transferred out of the Group and changed its name to Glenmore (2025) Limited.”
• “There are no significant post balance sheet events.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.